Cardlytics Inc expected to post a loss of 24 cents a share - Earnings Preview

Reuters
2024-11-05

* Cardlytics Inc is expected to show a fall in quarterly revenue when it reports results on November 6 for the period ending September 30 2024

* The Atlanta Georgia-based company is expected to report a 26.9% decrease in revenue to $57.791 million from $79.01 million a year ago, according to the mean estimate from 6 analysts, based on LSEG data.The company's guidance on August 7 2024, for the period ended September 30, was for revenue between $56.00 million and $63.00 million. (SAL basis is Total Revenue)

* ​LSEG's mean analyst estimate for Cardlytics Inc is for a loss of 24 cents per share.

* The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy," 5 "hold" and 1 "sell" or "strong sell."

* The mean earnings estimate of analysts was unchanged in the last three months. ​

* Wall Street's median 12-month price target for Cardlytics Inc is $4.00​, below​ its last closing price of $4.18. ​​​

The company's guidance on August 7 2024 for the period ended September 30 was for Earnings before Interest, Taxes, Depreciation and Amortization of between 56 million and -3.5 million $(USD)$. Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI

ENDING ARTESTIMAT ESTIMATE MET, SE %

E® MISSED

Jan. 1 0001 -0.11 -0.13 -0.15 Missed -19

Mar. 31 0001 -0.10 -0.11 -0.09 Beat 18.2

Jan. 1 0001 0.15 0.12 0.14 Beat 16.7​

Sep. 30 2023 -0.01 -0.01 0.01 Beat 200

​​Jun. -0.35 -0.35 -0.24 Beat 32.1

30 2023

Mar. 31 2023 -0.56 -0.56 -0.25 Beat 55.7​

Dec. 31 2022 -0.46 -0.46 -0.29 Beat 37.5

Sep. 30 2022 -0.50 -0.57 -0.50 Beat 12.3

This summary was machine generated November 4 at 21:45 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10